Report Interpretation
Covering the latest research from top Wall Street investment banks
Report InterpretationHilo Research

Kweichow Moutai (600519) Report Interpretation

Kweichow Moutai reported modest H126 revenue growth and a net-profit decline, with both figures below consensus amid weaker mix and soft macro demand. UBS sees a near-term negative reaction but retains its Buy rating and Rmb1,617 target price.

InstitutionUBS
Date20260816
CompanyKweichow Moutai
Ticker600519.SH
IndustryFood Products
RatingBuy

Summary

Kweichow Moutai reported modest H126 revenue growth and a net-profit decline, with both figures below consensus amid weaker mix and soft macro demand. UBS sees a near-term negative reaction but retains its Buy rating and Rmb1,617 target price.

Buy; 12-month price target Rmb1,617.00 versus Rmb1,341.99 on 14 Aug 2026; forecast price appreciation 20.5%.
Kweichow MoutaiBaijiuH126 earningsChannel reformDirect salesProduct mixBuy ratingChina consumer
  • H126 revenue/net profit were Rmb90,703mn/Rmb44,517mn, up 1.5% and down 2.0% year on year, respectively.
  • Revenue and net profit were 4% and 5% below consensus.
  • Q226 direct sales rose 34% year on year while distributor sales fell 35%, shifting the sales mix toward direct channels.
  • iMoutai revenue rose 283% year on year to Rmb18,711mn, or 51% of quarterly revenue.
  • UBS expects investors to react negatively to the weaker-than-expected result but says its long-term thesis is broadly unchanged.

Report Interpretation

Overview

UBS reviews Kweichow Moutai’s H126 results, which missed consensus as softer demand and channel-reform trade-offs weakened the product mix. The firm expects a negative immediate market reaction but maintains its long-term Buy view, citing continued channel reform and digital investment.

Core views

Kweichow Moutai reported H126 revenue of Rmb90,703mn, up 1.5% year on year, and net profit of Rmb44,517mn, down 2.0%. These were 4% and 5% below consensus, respectively. Implied Q226 revenue was Rmb36,794mn, down 5.1% year on year, while implied net profit was Rmb17,274mn, down 6.9%. UBS attributes the miss mainly to a weaker product mix in both Moutai liquor and series liquor—particularly non-standard Moutai products and the Moutai 1935 series—alongside a weak Q226 macro backdrop that peers also cited. Profitability weakened with the mix. H126 gross profit margin including tax fell 2.3 percentage points year on year to 73.4%. The selling-and-distribution ratio edged down 0.1 percentage point to 3.5%, and the G&A ratio also fell 0.1 percentage point, but these savings did not offset gross-margin pressure: operating margin declined 2.1 percentage points to 65.8% and net profit margin fell 1.7 percentage points to 49.1%. Segment trends show the imbalance. In H126, Moutai liquor revenue was Rmb77,724mn, up 2.8% year on year and representing 85.7% of revenue, while series-liquor revenue was Rmb12,934mn, down 6.0% and representing 14.3%. Their gross margins were 92.3% and 73.6%, down 1.6 and 4.0 percentage points, respectively. In Q226, Moutai liquor revenue declined 1% year on year to Rmb31,720mn, while series liquor declined 25% to Rmb5,053mn; their revenue shares were 86.2% and 13.7%. UBS characterizes the move toward direct sales as a double-edged channel reform. In Q226, direct sales increased 34% year on year and distributor sales fell 35%, changing their shares of total sales revenue to 61% and 39%, from 43% and 57% in Q225. iMoutai revenue increased 283% year on year to Rmb18,711mn, accounting for 51% of quarterly revenue. UBS believes the transition can help Moutai capture consumer demand more directly and improve pricing control over core Feitian, which had price increases in March and July. However, it has also reduced distributors’ bundled sales of higher-margin non-standard Moutai and Moutai 1935, contributing to the weaker mix. UBS expects investors to react negatively to the H126 shortfall. Nevertheless, it says its long-term investment thesis is broadly unchanged because the company continues to reform its channel strategy and invest in digital infrastructure. UBS expects further information at Moutai’s online H126 results meeting on 21 August.

Analysis framework

UBS compares reported H126 and implied Q226 revenue and profit with consensus, then traces the earnings shortfall through margins, product segments and sales channels. It frames the direct-sales transition as a trade-off between stronger consumer access and Feitian pricing control on one hand, and weaker distributor-led sales of higher-margin products on the other. The stated price target is derived using a DCF methodology.

Methodology notes

  • Valuation methodsDCF (Discounted Cash Flow)

    DCF methodology

    UBS states that it derives the price target from a discounted-cash-flow approach, which values the company using expected future cash flows discounted to present value.

  • Industry AnalysisVolume-price decomposition

    Product-mix, segment-margin and channel-mix analysis

    The report explains the earnings miss by separating Moutai liquor and series liquor performance, their margins, and the shift from distributor sales to direct sales.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Kweichow Moutai (600519.SS)
    Primary covered company; direct-sales channel reform is central to the earnings and long-term thesis.
    Strengths
    Direct sales and iMoutai can improve consumer-demand capture and pricing control over Feitian; UBS says the company continues to invest in digital infrastructure.
    Weaknesses
    Weaker product mix, declining series-liquor sales and lower margins contributed to the H126 earnings miss.
    Comparison
    H126 revenue and net profit were 4% and 5% below consensus, respectively.
    Risks
    Weak macro demand, capacity constraints, SOE-related growth limits, policy risks, food-safety issues and strategic errors.

Key data

  • H126 revenueRmb90,703mn+1.5% YoY; 4% below consensus
  • H126 net profitRmb44,517mn-2.0% YoY; 5% below consensus
  • Implied Q226 revenueRmb36,794mn-5.1% YoY
  • Implied Q226 net profitRmb17,274mn-6.9% YoY
  • H126 gross profit margin73.4%-2.3 percentage points YoY, including tax
  • H126 operating margin65.8%-2.1 percentage points YoY
  • H126 net profit margin49.1%-1.7 percentage points YoY
  • Q226 iMoutai revenueRmb18,711mn+283% YoY; 51% of quarterly revenue
  • 12-month price targetRmb1,617.00UBS DCF-derived target
  • Forecast stock return24.5%20.5% forecast price appreciation plus 4.0% forecast dividend yield

Impact & implications

UBS sees the result as evidence that channel reform carries a near-term earnings and mix cost. Direct sales may improve consumer reach and Feitian pricing control, but reduced distributor bundling has weakened sales of higher-margin non-standard products and Moutai 1935. The firm therefore expects a negative short-term reaction while retaining its longer-term thesis.

Risks

  • An economic downturn, including an acute property slowdown or falling property prices, could hurt premium-baijiu demand.
  • Capacity constraints could restrain sales growth even when demand is healthy.
  • The SOE structure could curb Moutai’s growth potential.
  • Government regulations or policies could negatively affect profitability.
  • Food-safety issues could damage the brand image.
  • Strategic errors are a stated risk.

What to watch

  • Moutai’s online H126 results meeting on 21 August, where UBS expects further disclosure.
  • Whether direct-sales expansion continues to improve Feitian pricing control without further weakening distributor-led sales of higher-margin products.
  • Macro demand conditions affecting premium baijiu.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins